
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : RLS-1496
Therapeutic Area : Dermatology
Study Phase : IND Enabling
Recipient : Rubedo Life Sciences
Deal Size : Undisclosed
Deal Type : Partnership
Rubedo Pulls in $40M Series A to Advance Atopic Dermatitis Candidate Targeting Aging Cells
Details : The financing will be utilized to fund the progress of the company’s primary candidate, RLS-1496, for treating patients with atopic dermatitis and chronic psoriasis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
April 22, 2024
Lead Product(s) : RLS-1496
Therapeutic Area : Dermatology
Highest Development Status : IND Enabling
Recipient : Rubedo Life Sciences
Deal Size : Undisclosed
Deal Type : Partnership
